Notice of Intent contact activation pathway function blocking antibody AB023
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Health Agency, through its Contracting Activity, intends to award a sole-source contract to Oregon Health & Science University for the supply of the contact activation pathway function blocking antibody AB023, in support of the United States Army Institute of Surgical Research. This determination follows a prior Request for Information that received no responses, leading the government to conclude that OHSU is the only viable source capable of fulfilling this specialized requirement. The contract action is classified under NAICS code 541714, which pertains to research and development in the physical, engineering, and life sciences, with a size standard of 1,000 employees. The solicitation number is HT9426-26-NOI-WS03, and while this notice is not a solicitation for competitive bids, responsible parties may still submit capability information by July 9, 2026, to demonstrate their ability to meet the requirement, though such submissions will only inform the government’s decision on competitiveness and carry no cost reimbursement. All submissions must be sent via email to the designated point of contact by the deadline, and the government retains full discretion to proceed with non-competitive award. The primary performance location is in San Antonio, Texas, while the contracting office is based in Fort Detrick, Maryland.
General Info
Agency
NAICS
Place of Performance
DWG, TX, 78234, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
The Defense Health Agency (DHA), Defense Health Agency Contracting Activity (DHACA), 808 Schreider Street, Fort Detrick, MD 21702, in support of the United States Army Institute of Surgical Research (USAISR) is issuing this notice of intent to procure items via Sole Source negotiation through the award of a contract to Oregon Health & Science University (OHSU). Under the contemplated award, Oregon Health & Science University, 3303 SW Bond Avenue, Portland, Oregon 97239, will provide contact activation pathway function blocking antibody AB023. Request for Information (RFI) HT9426-26-RFI-WS03 was posted on https://sam.gov from 12 June 2026 to 18 June 2026 with no responses received.
The North American Industry Classification System (NAICS) for this requirement is 541714 with a size standard of 1,000 employees.
THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS. Responsible, interested parties may identify their interest by submitting capability information by Thursday, 09 July 2026 at 12:00PM Eastern Standard Time in order to establish the ability of the responder to meet this requirement. A determination by the Government to not compete this proposed contract based upon responses received to this notice is solely within the discretion of the Government. Information received will be considered for the sole purpose of determining whether to conduct a competitive procurement. The Government will not be responsible for any costs associated with preparing responses to this notification. All inquiries must be submitted via email to william.a.shortall.civ@health.mil by 12PM Eastern Standard Time on 09 July 2026.